Vaccine-Preventable Neurological Diseases: A Global Threat

Vaccination has proudly stood as one of the shining achievements in public health throughout modern history. However, this success story is increasingly threatened by a concerning decline in vaccination coverage. Factors contributing to this decline include vaccine hesitancy and disruptions in immunization campaigns, particularly in regions plagued by geopolitical instability. The resurgence of vaccine-preventable diseases poses a significant public health risk, especially given the substantial global burden associated with vaccine-preventable neurological diseases. The consequences are far-reaching, leading not only to acute and chronic neurological complications but also alarmingly high case fatality rates.

Over the past few years, there has been a noticeable uptick in outbreaks of various vaccine-preventable diseases, including dengue, poliomyelitis, measles, pertussis, meningococcal diseases, and Japanese encephalitis. These outbreaks can be traced back to several factors: insufficient access to vaccines, overwhelmed health-care systems unable to cope with the demand, rampant misinformation and disinformation surrounding vaccine safety, and gaps in vaccination coverage that have been exacerbated by environmental factors and ongoing geopolitical conflicts. As these issues persist, the threat of a resurgence in vaccine-preventable neurological diseases looms ever larger.

Evidence indicates that the overwhelming misinformation regarding vaccine safety has contributed to a climate of distrust towards vaccines. Misinformation can spread rapidly across social media platforms, leading to widespread misconceptions that deter individuals from seeking vaccination. This phenomenon highlights the urgent need for robust public health communication strategies that provide clear, accurate information about the benefits and risks associated with vaccines. Engaging with communities directly and addressing their specific concerns can serve as a powerful tool in countering vaccine hesitancy and ensuring higher uptake rates.

It is important to recognize the interlinking nature of health systems and vaccination campaigns. Several regions with the highest rates of vaccine-preventable neurological diseases are experiencing strained healthcare resources due to various factors, including environmental disasters and ongoing conflicts. In such settings, health systems often lack the capacity to run effective vaccination campaigns, resulting in collateral damage in disease prevalence. To combat this, coordinated global strategies must address barriers to vaccination while simultaneously ensuring equitable access to immunization for all, particularly in underserved populations.

The impact of globalization cannot be overlooked in this context. As populations become more mobile, diseases do not respect borders; they travel with people. This means that high vaccination coverage in one region does not guarantee immunity for another region that may lag behind. It underscores the importance of maintaining vigilance and monitoring vaccination rates worldwide. A robust global response is imperative for preventing the cross-border transmission of vaccine-preventable diseases and, subsequently, neurological complications that arise from such infections.

Educational initiatives play a crucial role in the fight against vaccine-preventable diseases. Comprehensive health education campaigns can detail both the benefits of vaccines and the potential risks associated with not being vaccinated. Such initiatives should particularly target vulnerable populations, who may be disproportionately affected by misinformation and may lack access to reliable health information. By tailoring approaches to fit community needs, public health organizations can foster trust and improve vaccination uptake.

As the landscape of vaccination continues to evolve, advancements in next-generation vaccine technologies offer new avenues to bolster immunization efforts. Innovative vaccine platforms—such as mRNA vaccines—have gained prominence during the COVID-19 pandemic and possess significant potential for addressing multiple infectious diseases. These technologies offer speed, adaptability, and efficacy, making them promising alternatives as public health strategies evolve in response to emerging challenges.

Moreover, the integration of vaccination efforts with other public services can amplify their effectiveness. For example, incorporating vaccination campaigns into maternal and child health programs can ensure that children receive vaccinations during routine health visits. This not only simplifies the process for families but also enhances overall healthcare delivery, promoting a holistic approach to public health.

In tandem with these strategies, addressing the issue of antimicrobial resistance (AMR) is vital. Vaccines play a critical role in preventing infections that could otherwise lead to the use of antimicrobials. The development of vaccines designed specifically to tackle AMR becomes increasingly important, particularly as resistance continues to rise globally. Along with enhancing vaccination coverage, investment in research to develop vaccines targeting resistant pathogens can significantly impact global health outcomes.

Non-vaccine serotype replacement also presents a substantial challenge in vaccination strategies. As certain vaccine-specific serotypes are eradicated from the population, non-vaccine serotypes can fill the void, leading to new patterns of disease. This complicates vaccination efforts and emphasizes the need for ongoing vigilance and research in vaccine development. Continuous monitoring of serotype dynamics is essential to adapting immunization policies and ensuring that vaccines remain effective against evolving pathogens.

The interplay between vaccination efforts, healthcare access, and educational outreach demonstrates that a multifaceted approach is essential to mitigate the risks associated with vaccine-preventable neurological diseases. Collaborative efforts across global health sectors will help address not only the immediate impact of these diseases but also the systemic issues that allow them to flourish. In doing so, the global community can work tirelessly to preserve the gains made in vaccine coverage and combat the imminent threat posed by resurgent diseases.

In summary, as we navigate the complexities of vaccine-preventable diseases in today’s interconnected world, it is essential we do not lose sight of the critical role vaccines play in safeguarding public health. Comprehensive strategies that encompass access, education, and innovative vaccine development will be pivotal in our efforts to protect vulnerable populations from the devastating impact of vaccine-preventable neurological diseases and to strengthen global health security for generations to come.

Chow, F.C., Granerod, J., Kim, C.Y. et al. The global threat of vaccine-preventable neurological diseases.
Nat Rev Neurol (2025). https://doi.org/10.1038/s41582-025-01172-w